Gregory Behar serves as Executive at Aimmune Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gregory Behar has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 13, 2020 involved transacting 10,192 shares valued at $0.
Gregory Behar currently holds 18,032 shares of Aimmune Therapeutics, Inc. (AIMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Behar has been a net neutral trader of AIMT stock. They have purchased $0 and sold $0 worth of shares.
Gregory Behar's most recent insider trade was on Oct 13, 2020, when they sold 10,192 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $34.50 |
| Discretionary |
| May 27, 2020 | AIMT | $0 | Award | 7,840 | $N/A | Discretionary |
| May 23, 2019 | AIMT | $0 | Award | 6,442 | $N/A | Discretionary |
| May 23, 2018 | AIMT | $0 | Award | 3,750 | $N/A | Discretionary |